Is Paige AI worth it for a small pathology lab?

Paige AI is contact-only with enterprise pricing, making it cost-prohibitive for small labs processing under 10,000 slides annually. You'd be better off with open-source tools like QuPath or pay-per-use services from PathAI.

Does Paige AI integrate with Leica scanners?

Yes, Paige AI integrates with Leica whole-slide imaging systems, as well as Philips and Hamamatsu. Other scanner brands may not be supported, so check compatibility before committing.

How does Paige AI compare to PathAI?

Paige has more FDA-cleared modules (prostate, breast, GI, pan-cancer) and foundation models (Virchow2G, PRISM), while PathAI offers a similar research platform but with fewer regulatory approvals. Paige is stronger for clinical deployment; PathAI may be more flexible for research.

What's the cheapest Paige AI tier?

Paige AI does not publicly disclose pricing. There is no free tier or self-serve plan — you must contact sales for a custom quote, which typically targets large labs and pharma companies.

What are Paige AI's biggest limitations?

Key limitations: no public pricing, requires compatible scanners, focused only on H&E-stained cancer pathology (no non-cancer or special stains), and enterprise-only model locks out small labs. The Alba co-pilot is also early-stage with limited real-world deployment.

Is Paige AI good for breast cancer diagnosis?

Yes, Paige Breast Suite is FDA-cleared for identifying and classifying breast cancer on H&E biopsy and excision specimens. It is well-suited for high-volume breast pathology workflows.

Can Paige AI replace a pathologist?

No. Paige AI is an assistive tool that highlights suspicious regions but does not provide final diagnoses. Pathologists retain full responsibility for the report. It's designed to reduce workload and catch misses, not replace professional judgment.

How long does Paige AI take to set up?

For diagnostic modules, setup ranges from weeks to months due to scanner integration, LIS validation, and staff training. For foundation model API access, setup takes days to weeks. Custom development can take 6-12 months.

Healthcare

Paige AI

FDA-cleared AI for cancer pathology diagnosis and biomarker discovery

75/100Safe BetCustom pricingContact Sales

Paige remains the dominant player in AI cancer pathology with FDA-cleared diagnostics and top-tier foundation models, but its enterprise-only model and opaque pricing put it out of reach for smaller labs. Worth the investment for high-volume pathology groups and pharma R&D.

Best for

Large pathology labs seeking FDA-cleared AI-assisted diagnosis with high throughput
Biopharma companies needing biomarker discovery from H&E tissue samples
Researchers developing custom computational pathology models using foundation models
Pathology groups aiming to reduce turnaround time and address pathologist burnout

Not ideal for

Radiology or non-pathology imaging workflows
Small labs with low slide volumes and limited budget
Users seeking fully open-source AI pathology models

Visit Website

AdvancedFor diagnostic modules: weeks to months depending on scanner integration and regulatory validation. For foundation model licensing: days to weeks for API access. Custom AI development: 6-12 months.Web · APIAPI available4.9k viewsVerified 12d ago

Pricing

Custom pricing

Contact Sales4 hidden costs

Learning curve

Advanced

For diagnostic modules: weeks to months depending on scanner integration and regulatory validation. For foundation model licensing: days to weeks for API access. Custom AI development: 6-12 months.

Runs on

WebAPI

API available · 5 integrations

Who it's for

Pathologist in a large hospital labBiopharma researcherAI developer in a pharma company

Live sentiment

Is Paige AI actually worth it?

We scan live Reddit threads, YouTube comments, X posts, G2 reviews and other communities — and hand you an honest verdict in under a minute.

Honest verdict, not marketing
Real pros & cons from real users
Attributed quotes with receipts

Run a free scan

3 free scans · no card needed

Skip it if

Skip Paige AI if your lab handles fewer than 10,000 slides annually, has a tight budget for enterprise contracts, or requires AI for non-cancer or non-H&E pathology workflows.

The 30-second take

Biggest gripe

No public pricing; you must contact sales to get a quote, making it impossible to budget upfront.

Price reality

Paige's contact-only pricing targets large labs and pharma with budgets for enterprise AI. For smaller labs, consider open-source alternatives like QuPath or PathAI's pay-per-slide model. Paige is not cost-effective for low-volume settings.

In short

Paige AI — FDA-cleared AI for cancer pathology diagnosis and biomarker discovery. Best for Large pathology labs seeking FDA-cleared AI-assisted diagnosis with high throughput, Biopharma companies needing biomarker discovery from H&E tissue samples, Researchers developing custom computational pathology models using foundation models. Contact Sales pricing.

Viability Score

75/100

Safe Bet

How likely is Paige AI to still be operational in 12 months? Based on 4 signals — momentum (how recently it shipped), wrapper dependency, revenue model, and web presence.

momentum

funding runway

website health

wrapper dependency

100

Last calculated: July 2026

How we score →

Key Features

Prostate cancer detection and grading (FDA-cleared)
Breast cancer identification and classification (FDA-cleared)
GI tract benign/malignant detection (FDA-cleared)
Pan-cancer detection across multiple tissue types
Molecular biomarker discovery from H&E slides (OmniScreen)
Foundation models: Virchow, Virchow2, Virchow2G, Virchow2G-Mini, PRISM
Custom AI model development services
Regulatory strategy and commercialization support
Voice and text command co-pilot (Paige Alba)
Real-time AI insights during pathology review
Workflow optimization for pathologists
Trained on over 1.5 million slides
Pan-cancer AI modules for therapeutic targeting
Pre-built AI modules for drug discovery
Integration with Philips, Leica, Hamamatsu whole-slide imaging

About Paige AI

Contact SalesAdvancedAPI availableWeb · API

Paige AI is an enterprise-focused platform delivering FDA-cleared AI applications for cancer pathology, including detection, grading, and subtyping on H&E-stained whole-slide images. Designed for large pathology labs and biopharma researchers, Paige's suite covers prostate, breast, GI, and pan-cancer diagnostics, along with foundation models like Virchow2G and PRISM for custom AI development. The Paige Alba co-pilot integrates voice and text commands to streamline workflow, while OmniScreen services enable molecular biomarker discovery from tissue. Trained on over 1.5 million slides, Paige prioritizes accuracy and regulatory compliance. Unlike general-purpose AI tools, Paige is solely dedicated to cancer pathology, offering both ready-to-use clinical modules and customizable research services, though its contact-only pricing and enterprise focus limit accessibility for smaller labs.

Behind the Verdict

Paige AI is purpose-built for cancer pathology, not a generalist AI you can bend to your workflow. Its FDA-cleared modules for prostate, breast, GI, and pan-cancer diagnosis give it a regulatory moat few competitors match. If you run a high-volume pathology lab or a biopharma R&D team, the ability to plug in models like Virchow2G and get molecular biomarkers from H&E slides is a genuine time-saver. The Paige Alba co-pilot, with its voice and text commands, is a nice productivity layer on top of existing diagnostic tools. Where it bites: there's no transparent pricing—expect to negotiate a contract. Small labs with thin margins or low slide volumes will find the investment hard to justify. Compared to open-source alternatives like PathML or CLAM, Paige offers regulatory support and ready-built clinical modules but locks you into their ecosystem. In practice, we'd reach for Paige when compliance and throughput matter more than cost control. For exploratory research, an open-source path might give more flexibility.

Researching Paige AI? Get your full AI stack in 60 seconds.

Free, no signup — tell us your goal and get tools matched to your budget & existing stack.

Real-world workflow fit

Concrete scenarios for the personas Paige AI actually fits — and what changes day-one when you adopt it.

Pathologist in a large hospital lab

Reviewing 50+ prostate biopsy slides daily

Outcome: Paige Prostate Suite highlights suspicious regions, reducing review time by 30% and catching missed lesions.

Biopharma researcher

Screening tissue samples for MSI biomarker in colorectal cancer

Outcome: Use OmniScreen to predict MSI status from H&E slides, avoiding costly molecular testing.

AI developer in a pharma company

Building a custom model for lung cancer subtyping

Outcome: Fine-tune Virchow2G foundation model using internal data, accelerated by Paige's expert services.

Use Cases

Prostate cancer detection and grading on H&E needle biopsies
Breast cancer identification in biopsy and excision specimens
GI tract condition detection (colon, gastric, etc.)
Pan-cancer detection including rare cancer types
Molecular biomarker discovery (e.g., MSI, HER2) via OmniScreen
Custom AI model development for pharmaceutical drug discovery

Models Under the Hood

VirchowVirchow2Virchow2GVirchow2G-MiniPRISM

as of 2026-07-06

Limitations

Pricing is not publicly disclosed, requiring sales contact, which may be a barrier for smaller labs.
The platform is specialized for cancer pathology; non-cancer diagnostics are not covered.
Integration may require compatible scanner systems (Philips, Leica, Hamamatsu) and LIS compatibility.
Some modules like Alba may be early-stage and not widely deployed.

as of 2026-06-29

Hidden costs & gotchas

What the public pricing page doesn't put in bold. Captured from pricing-page footnotes, contract terms, and recurring complaints.

No public pricing; you must contact sales to get a quote, making it impossible to budget upfront.
You likely need compatible whole-slide scanners (Philips, Leica, or Hamamatsu) which can be a significant capital expense.
Custom AI development services and regulatory support are billed separately and can add substantial costs.
Annual contracts are typical for enterprise software, locking you in for a full year even if usage drops.

Where the pricing makes sense

The company stage and team size where Paige AI's pricing actually pencils out — and where peers do it cheaper.

Setup time & first value

How long it actually takes to get something useful out of Paige AI — broken out by persona, not the marketing-page minute.

For diagnostic modules: weeks to months depending on scanner integration and regulatory validation. For foundation model licensing: days to weeks for API access. Custom AI development: 6-12 months.

Switching to or from Paige AI

How to bring data in from common predecessors and how to get it back out — written for the switcher, not the buyer.

Migrating in

→From manual microscopy: digitize slides with compatible scanner, validate Paige AI modules with existing LIS.

Migrating out

↗To open-source alternative: export labeled data and model checkpoints, retrain using frameworks like PyTorch.

Integrations

Philips whole-slide imagingLeica whole-slide imagingHamamatsu whole-slide imagingMicrosoft AzureAWS

Resources & Guides

Official links

Official Website

Tools that pair well with Paige AI

Common stack mates teams adopt alongside Paige AI, with the specific reason each pairing earns its keep.

Recursion

AI-driven drug discovery platform using phenomics and massive biological datasets

Evotec

AI-driven end-to-end drug discovery and biologics manufacturing platform

Nimbus Therapeutics

AI-driven small molecule drug discovery for selective oncology and immunology

Alternatives to Paige AI

View all

Frequently Asked Questions

Best-of guides

Best AI Tools for Compliance & GRC

Topics

Research Data Analysis

Used Paige AI? Help shape our editorial sentiment research.